Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL).
Wong LM, Sutherland T, Perry E, Tran V, Spelman T, Corcoran N, Lawrentschuk N, Woo H, Lenaghan D, Buchan N, Bax K, Symons J, Saeed Goolam A, Chalasani V, Hegarty J, Thomas L, Christov A, Ng M, Khanani H, Lee SF, Taubman K, Tarlinton L. Wong LM, et al. Among authors: symons j. Eur Urol Oncol. 2024 Oct;7(5):1015-1023. doi: 10.1016/j.euo.2024.01.002. Epub 2024 Jan 27. Eur Urol Oncol. 2024. PMID: 38281891 Free article. Clinical Trial.
Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study).
Woo HH, Khanani H, Thompson NJ, Sorensen BJ, Baskaranathan S, Bergersen P, Chalasani V, Dean T, Dias M, Symons J, Wines M, Jain A, Nassour AJ, Tarlinton LC. Woo HH, et al. Among authors: symons j. Eur Urol Open Sci. 2022 Dec 16;47:119-125. doi: 10.1016/j.euros.2022.11.012. eCollection 2023 Jan. Eur Urol Open Sci. 2022. PMID: 36601041 Free PMC article.
The effect of different assays on prostate-specific antigen testing.
Jain A, Nassour AJ, Symons JL, Chung A, Goolam AS, Wines MP, Chalasani V, Dias M, Collins R, Indrajit B, Woo HH. Jain A, et al. BJU Int. 2023 Jun;131(6):689-691. doi: 10.1111/bju.15958. Epub 2023 Mar 6. BJU Int. 2023. PMID: 36877934 No abstract available.
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial.
Nair-Shalliker V, Smith DP, Gebski V, Patel MI, Frydenberg M, Yaxley JW, Gardiner R, Espinoza D, Kimlin MG, Fenech M, Gillatt D, Woo H, Armstrong BK, Rasiah K, Awad N, Symons J, Gurney H. Nair-Shalliker V, et al. Among authors: symons j. BMJ Open. 2021 Mar 2;11(3):e044055. doi: 10.1136/bmjopen-2020-044055. BMJ Open. 2021. PMID: 33653757 Free PMC article.
High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse.
Savdie R, Symons J, Spernat D, Yuen C, Pe Benito RA, Haynes AM, Matthews J, Rasiah KK, Jagavkar RS, Yu C, Fogarty G, Kattan MW, Brenner P, Sutherland RL, Stricker PD. Savdie R, et al. Among authors: symons j. BJU Int. 2012 Dec;110 Suppl 4:71-6. doi: 10.1111/j.1464-410X.2012.11480.x. BJU Int. 2012. PMID: 23194129
457 results